Skip to main content

Table 3 Utilization and cost of diabetes testing supplies by Type of Diabetes and Treatment, Saskatchewan 2001

From: Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001

  Number of Cases Number (%) of Subjects with ≥ 1 record for testing supplies Average (SD) Number of Records Average (SD) DP share (Can$) Average (SD) Patient Share (Can$) Average (SD)A, BTotal (Can$)
Type 1 4005 3143 (78.5) 5.8 (6.4) 231.71 (408.53)A 240.60 (343.81)A 472.31 (560.75)A
(% of Total) (9.6%)    (49.1%) (50.9%)  
Type 2       
   No medication 14157 3169 (22.4%) 0.5 (1.5) 11.78 (62.14)B 23.69 (72.61)B 35.47 (107.22)B
(% of Type 2) (37.6%)    (33.2%) (66.8%)  
   Oral anti-diabetic agent only 18910 11814 (62.5) 2.0 (2.6) 57.78 (132.42) 73.42 (110.65) 131.21 (189.78)
(% of Type 2) (50.3%)    (44.0%) (56.0%)  
   Insulin only 2212 1751 (79.2) 4.6 (5.0) 194.53 (296.40) 153.33 (233.26) 347.86 (409.39)
(% of Type 2) (5.9%)    (55.9%) (44.1%)  
   Insulin and oral anti-diabetic agent 2346 2037 (86.8) 4.9 (4.4) 220.08 (286.55) 148.48 (187.50) 368.56 (362.67)
(% of Type 2) (6.2%)    (59.7%) (40.3%)  
Type 2 Total 37625 18771 (49.9) 1.8 (2.9) 58.63 (155.18)A 64.09 (122.86)A 122.72 (233.88)A
(% of Total) (90.4%)    (47.8%) (52.2%)  
  1. A p < 0.001 between type 1 and type 2 diabetes using the Kruskal Wallis Test
  2. B p < 0.001 between treatment groups within type 2 diabetes (i.e. no medication, oral anti-diabetic agent only, insulin only, insulin and oral anti-diabetic agent) using the Kruskal Wallis Test